Women’s Health

Aspira Women’s Health Appoints Nicole Sandford to its Board of Directors

Aspira Women’s Health, a bioanalytical-based women’s health company, today announced the appointment of Nicole Sandford to its Board of Directors. The company is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for women. “I am very pleased to warmly welcome Nicole…

Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market

Hologic, a global leader in women’s health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics for approximately $230M. Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers. “We are very pleased to complete the acquisition of Biotheranostics and look forward to working with our new colleagues to grow in the large, rapidly expanding oncology space,”…

Nike and ABOUT YOU Launch a Co-Branded Campaign Addressing the Power of the Menstrual Cycle

The menstrual cycle is still a taboo topic in public discourse. Nike and ABOUT YOU have taken this as an opportunity to address the relevant topic of the menstrual cycle in their jointly developed campaign for the launch of the new Nike SuperRep training shoe in Germany. Goal of the campaign is to motivate women to find out about their menstrual cycle…

Swiss Femtech Startup CorDiFio Is Building an AI-powered Platform to Improve Heart Disease Diagnostics

Although 80% of cardiovascular diseases including stroke are preventable, heart diseases are the #1 cause of death in women today. Shockingly enough, however, around 50% of women, who have had a heart attack, get misdiagnosed with stress or anxiety. “We are a half-century behind in our knowledge about optimal screening, diagnosis, and treatment of heart disease in women. Every day, women pay…

Women’s Health Wednesday: Why Femtech Innovators Are Flocking to Clubhouse on Wednesdays

Yep. Clubhouse is hard to ignore and has also reached our femtech fam. And there is one event series on the audio-only social network, that has us excited every week: Women’s Health Wednesdays. The series is hosted by a group around angel investor and Forbes journalist Bérénice Magistretti. Other regulars include Janine Kopp (PERLA Health co-founder) and Jan Deruyck (Guud Woman co-founder)…

Launched: LaMaria, A New Line of Skincare for Menopausal Women Created by an OB-GYN

Menopause startups are on the rise – both in numbers and in terms of the capital and attention they attract. Today another company focused on menopausal women joins their ranks: LaMaria – A skincare brand that’s pro-you instead of anti-age. The DTC company was founded by OB-GYN Dr. Manuela Maria Vazquez who wanted to create a product specifically for women undergoing hormonal…

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Ferring Pharmaceuticals, Rebiotix, a Ferring Company, and MyBiotics Pharma today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility. The collaboration is an important step forward in harnessing the power of the human microbiome in this area…

Evofem Launches Its First DTC Advertising Campaign to Accelerate Awareness of Phexxi, Its Non-Hormonal Birth Control Option for Women

Earlier today Evofem announced the launch of “Get Phexxi”, a national direct-to-consumer campaign aimed at broadening awareness of its non-hormonal, use-it-only-when-you-need-it birth control method, Phexxi Approved by the U.S. Food and Drug Administration (FDA) in May 2020, Phexxi is an innovative non-hormonal contraceptive method created for women.  With 21 million women in the U.S. at risk for pregnancy who are NOT using hormonal contraception, the company feels the time is…